Trademarks / Patents / IP Old long list of patents circa 2017

johnnytech

Moderator
Staff member
Originally posted by ajshare

Patents by Clinuvel

1 9801924 Therapy for vitiligo

2 US20170304406 NEW INDICATION FOR ALPHA-MSH ANALOGUES

3 EP2865422B1 Alpha-MSH derivatives for the treatment of photodermatoses

4 EP3212220A1 INFLAMMATORY DISEASE

5 EP3212219A1 NEW INDICATION FOR ALPHA-MSH ANALOGUES

6 US20170143796 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

7 9572775 Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses

8 US20160296589 COMPOSITIONS AND METHODS FOR TREATING VITILIGO

9 9447164 Engineered nucleic acids and methods of use thereof

10 US20160235819 METHODS OF INDUCING MELANOGENESIS IN A SUBJECT

11 9345911 Methods of inducing melanogenesis in a subject

12 WO/2016/066702A1 INFLAMMATORY DISEASE

13 WO/2016/066700A1 NEW INDICATION FOR ALPHA-MSH ANALOGUES

14 US20160058873 Cyclodextrin-Based Polymers for Therapeutic Delivery

15 US20160024171 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

16 EP1789076B1 METHODS OF INDUCING MELANOGENESIS IN A SUBJECT.

17 EP2957292A1 THERAPY FOR VITILIGO

18 9181319 Engineered nucleic acids and methods of use thereof

19 EP2939686A1 COMPOSITIONS AND METHODS FOR INDUCING MELANOGENESIS IN A SUBJECT

20 EP2278992B1 THERAPY FOR VITILIGO

21 EP2368562B1 Compositions and methods for inducing melanogenesis in a subject

22 WO/2015/067503A1 ALPHA-MSH ANALOGUES FOR USE IN THE TREATMENT OF PSORIASIS

23 WO/2015/063102A1 ALPHA-MSH ANALOGUES FOR USE IN BULLOUS DISEASE

24 WO/2015/063099A1 ALPHA-MSH ANALOGUES FOR USE IN THE TREATMENT OF HAILEY-HAILEY DISEASE

25 EP2865422A1 Alpha-MSH derivatives for the treatment of photodermatoses

26 JP2015052012A THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

27 JP5655147B2 A complex of therapeutic peptide * polymer, particles, a constituent, and a method of relation

28 EP2056855B1 ALPHA-MSH DERIVATIVES FOR THE TREATMENT OF PHOTODERMATOSES

29 8822663 Engineered nucleic acids and methods of use thereof

30 US20140243399 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

31 US20140213504 Cyclodextrin-Based Polymers for Therapeutic Delivery

32 US20140135254 THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

33 JP5449673B2 A constituent and a method for guiding the melanin formation in a candidate

34 EP1689349B9 A METHOD OF INDUCING MELANOGENESIS IN HUMANS WITH MC1R VARIANT ALLELES

35 US20130344153 METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS

36 EP2673295A1 HEXAPEPTIDE WITH IMPROVED ACTIVITY IN THE REPAIR OF CELLULAR DNA OF DERMAL CELLS

37 US20130331331 HEXAPEPTIDE WITH IMPROVED ACTIVITY IN THE REPAIR OF CELLULAR DNA OF DERMAL CELLS

38 8569234 Compositions and methods for including melanogenesis in a subject

39 JP2013536198A The complex of therapeutic peptide * polymer, particles, a constituent, and the method of relation

40 EP1689349B1 A METHOD OF INDUCING MELANOGENESIS IN HUMANS WITH MC1R VARIANT ALLELES

41 US20130210724 Cyclodextrin-Based Polymers for Therapeutic Delivery

42 US20130203670 Therapy For Vitiligo

43 JP5230941B2 How to guide melanin formation in the humans who have a MC1R mutant allele

44 EP2056855A4 METHOD OF TREATMENT OF PHOTODERMATOSES

45 JP5208504B2 A method for guiding melanin formation by a candidate

46 8334265 Method of treatment of photodermatoses

47 US20120302505 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

48 WO/2012/145632A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

49 WO/2012/131090A1 METHOD FOR TREATMENT OF XERODERMA PIGMENTOSUM

50 WO/2012/107592A1 HEXAPEPTIDE WITH IMPROVED ACTIVITY IN THE REPAIR OF CELLULAR DNA OF DERMAL CELLS

51 EP2487185A1 Hexapeptide with improved activity in the repair of cellular DNA of dermal cells

52 US20120065252 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

53 US20120052097 THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

54 WO/2012/024530A2 THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

55 WO/2012/019168A2 ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF

56 WO/2011/134026A1 COSMETIC METHODS AND COMPOSITIONS

57 US20110263508 Compositions and methods for including melanogenesis in a subject

58 EP2368562A1 Compositions and methods for inducing melanogenesis in a subject

59 EP2056854A4 METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS

60 EP1789076A4 METHODS OF INDUCING MELANOGENESIS IN A SUBJECT.

61 US20110130705 THERAPY FOR VITILIGO

62 EP2278992A2 THERAPY FOR VITILIGO

63 US20110020252 METHOD OF LONG LASTING HUMAN SKIN TANNING

64 EP2259794A1 METHOD FOR TREATMENT OF PHOTOSENSITIVITY AND PHOTOTOXICITY

65 7745408 Method of inducing melanogenesis in humans with MC1R variant alleles

66 US20100120668 METHOD OF TREATMENT OF PHOTODERMATOSES

67 US20100113337 METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS

68 WO/2009/118191A3 THERAPY FOR VITILIGO

69 WO/2009/118191A2 THERAPY FOR VITILIGO

70 WO/2009/103816A1 METHOD FOR TREATMENT OF PHOTOSENSITIVITY AND PHOTOTOXICITY

71 EP1812034A4 COMPOSITIONS AND METHODS FOR INDUCING MELANOGENESIS IN A SUBJECT

72 EP2056855A1 METHOD OF TREATMENT OF PHOTODERMATOSES

73 EP2056854A1 METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS

74 US20080305152 Methods of Inducing Melanogenesis in a Subject

75 EP1689349A4 A METHOD OF INDUCING MELANOGENESIS IN HUMANS WITH MC1R VARIANT ALLELES

76 JP2008515815A The composite and method for guiding the melanin formation in a candidate

77 JP2008508324A The method for guiding melanin formation by a candidate

78 WO/2008/033395A3 MELANOCORTIN AND TRANSFERRIN FUSION PROTEINS

79 WO/2008/033395A2 MELANOCORTIN AND TRANSFERRIN FUSION PROTEINS

80 WO/2008/025094A1 METHOD OF TREATMENT OF PHOTODERMATOSES

81 WO/2008/025074A1 METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS

82 US20080004213 Method of Inducing Melanogenesis in Humans With Mc1R Variant Alleles

83 US20070265952 SYSTEMS AND METHODS FOR INVESTING

84 US20070255633 SYSTEMS AND METHODS FOR INVESTING

85 EP1812034A1 COMPOSITIONS AND METHODS FOR INDUCING MELANOGENESIS IN A SUBJECT

86 JP2007514656A How to guide melanin formation in the humans who have a MC1R mutant allele

87 EP1789076A1 METHODS OF INDUCING MELANOGENESIS IN A SUBJECT.

88 EP1689349A1 A METHOD OF INDUCING MELANOGENESIS IN HUMANS WITH MC1R VARIANT ALLELES

89 WO/2006/037188A1 COMPOSITIONS AND METHODS FOR INDUCING MELANOGENESIS IN A SUBJECT

90 WO/2006/012667A1 METHODS OF INDUCING MELANOGENESIS IN A SUBJECT.

91 WO/2005/048967A1 A METHOD OF INDUCING MELANOGENESIS IN HUMANS WITH MC1R VARIANT ALLELES
 

CUV Quote (Yesterday's close)

Time: 4:10PM AEST
Price: 43.58
Volume: 206806
Top